Functionalized Graphene Oxide with Chitosan for Protein Nanocarriers to Protect against Enzymatic Cleavage and Retain Collagenase Activity
- PMID: 28186169
- PMCID: PMC5301474
- DOI: 10.1038/srep42258
Functionalized Graphene Oxide with Chitosan for Protein Nanocarriers to Protect against Enzymatic Cleavage and Retain Collagenase Activity
Abstract
Proteins have short half-life because of enzymatic cleavage. Here, a new protein nanocarrier made of graphene oxide (GO) + Chitosan (CS) is proposed to successfully prevent proteolysis in protein and simultaneously retain its activity. Bovine serum albumin (BSA) and collagenase were loaded on GO and GO-CS to explore the stability and activity of proteins. SEM, AFM, TEM, DSC, UV-Vis, FT-IR, RBS, Raman, SDS-PAGE and zymography were utilized as characterization techniques. The protecting role of GO and GO-CS against enzymatic cleavage was probed by protease digestion analysis on BSA, where the protease solution was introduced to GO-BSA and GO-CS-BSA at 37 °C for 0.5-1-3-6 hours. Characterizations showed the successful synthesis of few layers of GO and the coverage by CS. According to gelatin zymographic analysis, the loaded collagenase on GO and GO-CS lysed the gelatin and created non-staining bands which confirmed the activity of loaded collagenase. SDS-PAGE analysis revealed no significant change in the intact protein in the GO-BSA and GO-CS-BSA solution after 30-minute and 1-hour exposure to protease; however, free BSA was completely digested after 1 hour. After 6 hours, intact proteins were detected in GO-BSA and GO-CS-BSA solutions, while no intact protein was detected in the free BSA solution.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
References
-
- Alonso-Sande M., Csaba N. S. & Alonso M. J. New perspectives in oral peptide and protein delivery: from nanocarrier design to in vivo effectiveness. New perspectives, 46–64 (2016).
-
- Gupta S. et al. Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug delivery 20, 237–246 (2013). - PubMed
-
- Moroz E., Matoori S. & Leroux J.-C. Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts. Advanced drug delivery reviews 101, 108–121 (2016). - PubMed
-
- Leader B., Baca Q. J. & Golan D. E. Protein therapeutics: a summary and pharmacological classification. Nature Reviews Drug Discovery 7, 21–39 (2008). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
